NCT07044206View on ClinicalTrials.gov

Comparaison of Interbody Bone Fusion Between Two Osteoinductive Bioactive Bone Substitutes After Anterior Lumbar Interbody Arthrodesis in Degenerative Lumbar Disc Surgery in Adults

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions
Disc Degeneration
Interventions
DEVICE

Use of bone substitute during intervertebral fusion surgery

Participants randomized will receive bone substitute during intervertebral fusion surgery. Routine postoperative follow-up procedure (identical for both groups) with two postoperative visits at 3 months and 12 months.

Trial Locations (1)

34295

CHU de Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT07044206 - Comparaison of Interbody Bone Fusion Between Two Osteoinductive Bioactive Bone Substitutes After Anterior Lumbar Interbody Arthrodesis in Degenerative Lumbar Disc Surgery in Adults | Biotech Hunter | Biotech Hunter